Artigo Revisado por pares

Increased Expression of RelA/Nuclear Factor-κB Protein Correlates with Colorectal Tumorigenesis

2003; Karger Publishers; Volume: 65; Issue: 1 Linguagem: Inglês

10.1159/000071203

ISSN

1423-0232

Autores

Honggang Yu, Liangliang Yu, Yanning Yang, Hesheng Luo, Jie‐Ping Yu, Juris J. Meier, Henning Schrader, Andreas Bastian, Wolfgang E. Schmidt, Frank Schmitz,

Tópico(s)

Colorectal Cancer Treatments and Studies

Resumo

<i>Objective: </i>To identify the role of RelA/nuclear factor-ĸB, an important inhibitor of apoptosis in colorectal tumorigenesis, we examined the expression of RelA in normal colorectal mucosa (n = 10), colorectal adenomas (n = 30) and colorectal adenocarcinomas (n = 30). Furthermore, the association of RelA expression with tumor cell apoptosis, proliferation, and expression of Bcl-2/Bcl-x<sub>L </sub>was also studied. <i>Methods: </i>Paraffin sections were stained with monoclonal antibodies directed against RelA, Bcl-2, Bcl-x<sub>L</sub>, and Ki-67 to assess protein expression patterns in normal, adenomatous and colon cancer tissue. Apoptotic cells were detected by terminal deoxynucleotidyl-transferase-mediated dUTP-biotin nick end labeling (TUNEL) using an in situ detection kit.<i> Results:</i> The results of immunohistochemical staining revealed that expression of RelA, Bcl-2, Bcl-x<sub>L</sub>, and Ki-67 labeling index (LI) significantly increased in the transition from adenoma with low dysplasia to adenocarcinoma. This transition was associated with a significant decrease in the apoptotic index (AI) and a significant increase in the Ki-67 LI. The expression of RelA correlated inversely with the AI and correlated positively with the expression of Bcl-2, Bcl-x<sub>L</sub>, and Ki-67 LI in the transition from low-grade dysplasia to adenocarcinoma. <i>Conclusion:</i> Our results suggest that increased expression of RelA/nuclear factor-ĸB plays an important role in the transition from colorectal adenoma with low-grade dysplasia to adenocarcinoma in the pathogenesis of colon cancer in humans.

Referência(s)
Altmetric
PlumX